| Literature DB >> 27546281 |
Rosario Caltabiano1, Lidia Puzzo2, Valeria Barresi3, Antonio Ieni3, Carla Loreto4, Giuseppe Musumeci4, Paola Castrogiovanni4, Marco Ragusa5, Pietro Foti6, Andrea Russo7, Antonio Longo7, Michele Reibaldi7.
Abstract
Uveal melanoma is the most frequent primary intraocular neoplasm in adults. Although malignant melanoma may be located at any point in the uveal tract, the choroid and ciliary body are more frequent locations than the iris. In the present study, we examined ADAM10 expression levels in primary uveal melanoma both with and without metastasis, and we evaluated their association with other high risk characteristics for metastasis in order to assess if ADAM10 can be used to predict metastasis. This study included a total of 52 patients, 23 men and 29 women, with uveal melanoma. A significantly high expression of ADAM-10 was seen in patients with metastasis (11/13, 84.6%), but not in patients without metastasis (15/39, 38.5%). In conclusion we found that ADAM10 expression was associated with a more rapid metastatic progression confirming its role in uveal melanoma metastasis.Entities:
Keywords: ADAM 10; Immunohistochemistry; Metastasis; Prognosis; Uveal melanoma
Mesh:
Substances:
Year: 2016 PMID: 27546281 DOI: 10.1016/j.prp.2016.08.003
Source DB: PubMed Journal: Pathol Res Pract ISSN: 0344-0338 Impact factor: 3.250